skip to main content


Commission strengthens support for treatment through convalescent plasma

Today, the European Commission invited more than 200 blood-collection services around the EU to apply for funding for the purchase of plasmapheresis equipment which takes plasma from donors. The aim of this action, part of the Emergency Support Instrument (ESI), is to support the treatment of new COVID-19 patients by increasing EU capacity to collect convalescent plasma recovered from COVID-19 patients. Plasma transfusion is also used to purify antibodies to make a COVID-19 specific medicinal product as short-term alternative to vaccines.

date:  31/07/2020

permalinkMain URL